Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1968 1
1973 2
1974 1
1980 1
1981 1
1984 5
1985 3
1987 2
1988 4
1989 3
1990 2
1991 4
1992 5
1993 1
1994 1
1997 4
1998 4
1999 2
2000 3
2001 1
2002 4
2003 7
2004 9
2005 11
2006 11
2007 7
2008 12
2009 12
2010 10
2011 12
2012 20
2013 16
2014 16
2015 23
2016 12
2017 20
2018 24
2019 36
2020 45
2021 37
2022 40
2023 33
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Results by year

Filters applied: . Clear all
Page 1
Hypoxia as a driver of resistance to immunotherapy.
Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las Rivas J, Riganti C. Kopecka J, et al. Drug Resist Updat. 2021 Dec;59:100787. doi: 10.1016/j.drup.2021.100787. Epub 2021 Nov 18. Drug Resist Updat. 2021. PMID: 34840068 Free article. Review.
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM. Galluzzi L, et al. J Immunother Cancer. 2020 Mar;8(1):e000337. doi: 10.1136/jitc-2019-000337. J Immunother Cancer. 2020. PMID: 32209603 Free PMC article. Review.
Impact of cancer metabolism on therapy resistance - Clinical implications.
Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Gonçalves AC, et al. Drug Resist Updat. 2021 Dec;59:100797. doi: 10.1016/j.drup.2021.100797. Epub 2021 Dec 16. Drug Resist Updat. 2021. PMID: 34955385 Free article. Review.
Doxorubicin-antioxidant co-drugs.
Chegaev K, Riganti C, Rolando B, Lazzarato L, Gazzano E, Guglielmo S, Ghigo D, Fruttero R, Gasco A. Chegaev K, et al. Bioorg Med Chem Lett. 2013 Oct 1;23(19):5307-10. doi: 10.1016/j.bmcl.2013.07.070. Epub 2013 Aug 8. Bioorg Med Chem Lett. 2013. PMID: 23973213 Free article.
Advocating for evidence-informed decisions to make healthcare fit for each person.
Franco JVA, Dwan K, Garegnani LI, Kunneman M, Madrid E, Metzendorf MI, Meza N, Nunan D, Richards GC, Riganti P, Veroniki AA. Franco JVA, et al. BMJ Evid Based Med. 2022 Apr;27(2):65-66. doi: 10.1136/bmjebm-2022-111953. Epub 2022 Mar 10. BMJ Evid Based Med. 2022. PMID: 35273013 No abstract available.
428 results